Stocks
Intellia Therapeutics (NTLA) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -7.48 | -24.3 | -32.3 | -5.48 | -5.62 | -5.12 | ||
| Changes by years, y/y, % | +9% | +224% | +33% | -83% | +3% | -4.0% | |||
Intellia Therapeutics. P/E
Intellia Therapeutics. P/E, changes, %
Intellia Therapeutics (NTLA) P/E US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/E | ? | -6.16 | -5.86 | -5.41 | -4.27 | -3.97 | -5.12 | |
| Changes by years, y/y, % | -36% | -1% | -30% | -47% | -35% | |||
| Changes by quarters, q/q, % | -24% | -5% | -8% | -21% | -7% | |||
